In this presentation, Dr. Carol Greenlee, endocrinologist, discusses the relationship of diabetes, liver disease and HCV infection. Dr. Greenlee provides an overview of extra hepatic manifestations of HCV infection, HCV… […]
Keyword: hcc
Screening for Hepatocellular Carcinoma | October 18, 2023
Incidence of hepatocellular carcinoma (HCC) is rising quickly in the United States, and AI/AN people are being affected greater than any other group. In this presentation, Dr. Jon Gerry, surgeon… […]
Read More… from Screening for Hepatocellular Carcinoma | October 18, 2023
Diabetes and HCV | April 5, 2023
In this presentation, Dr. Carol Greenlee, endocrinologist, discusses the relationship of diabetes, liver disease and HCV infection. Dr. Greenlee provides an overview of extra hepatic manifestations of HCV infection, HCV… […]
Residual Risk for HCC in Patients After HCV SVR | February 23, 2022
In this presentation, Dr. Raymond Chung, 2021 AASLD President and Director of Hepatology and the Liver Center at Massachusetts General Hospital, discusses the residual risk for hepatocellular carcinoma in patients after… […]
Read More… from Residual Risk for HCC in Patients After HCV SVR | February 23, 2022
Diabetes and HCV | December 9, 2021
In this video, Dr. Carol Greenlee, endocrinologist, discusses management of type 2 diabetes in patients with Hepatitis C Virus (HCV). Dr. Greenlee provides an overview of how HCV can potentially… […]
Screening for Hepatocellular Carcinoma | June 23, 2021
Incidence of hepatocellular carcinoma (HCC) is rising quickly in the United States, and AI/AN people are being affected greater than any other group. In this presentation, Dr. Jon Gerry, surgeon… […]
Read More… from Screening for Hepatocellular Carcinoma | June 23, 2021